Fox Chase Researchers Present Findings on Uptake of Aspirin for Lynch Syndrome Chemoprevention at 2024 CGA-IGC Meeting
PHILADELPHIA (November 14, 2024) — In patients with Lynch syndrome, the use of aspirin as a form of chemoprevention is lower than anticipated, according to a new study by researchers at Fox Chase Cancer Center to be presented at the 2024 meeting of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC).